NYSE · Drug Manufacturers - General

Eli Lilly and Company (LLY)

$1,347.11 -0.30%
50 In band Daily RSI (14) · 19 Nov 2026

Moving averages

SMA 50$1,265.60+134,611.00%
SMA 200$1,099.63+134,611.00%
EMA 20$1,367.71+134,611.00%

Company profile

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.

SectorHealthcare
IndustryDrug Manufacturers - General
Market cap$1.26T
P/E ratio43.94
EPS$32.13
Beta0.389
Dividend yield0.49%
52-week high$1,453.00
52-week low$847.83

Insider transactions

ExecutiveTitleActionSharesDate
JONSSON, PATRIKEVP & President, LLY Int'lG7042026-11-10
RICKS, DAVID ADirector, President, Chair, and CEOG23,5382026-11-03
HAKIM, ANATEVP, GC & SecretaryS5,0002026-11-02
Sign in: free for 30 days

Latest news

Earnings call transcript

Q3 2026

Ladies and gentlemen, thank you for standing by, and welcome to the Eli Lilly Third Quarter 2026 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will be conducting a question-and-answer session and providing instructions. Should you require operator assistance during the call, please press star, and an operator will assist you offline. I would now like to turn the conference over to your host, Michael Czapar, Senior Vice President of Investor Relations. Please go ahead.…

Sign in: free for 30 days

Options chain

TypeStrikeExpiryVolumeOpen interest
Call$1,500.002026-11-202,9581,139
Call$1,520.002026-11-201,9141,273
Call$1,560.002026-11-201,0752,385
Sign in: free for 30 days

ETFs holding LLY

Similar stocks in Drug Manufacturers - General

30 days of PRO Unlimited free, no card

RSI alerts for LLY

An email when LLY closes below RSI 30 or above 70. Nothing else.

Data last updated 21 November 2026 at 8:58 PM EST